News for Amarin Corporation plc (ADR) - Google Finance

Amarin Corporation plc (ADR) (AMRN): What's The Smart Money Think?

Tue, 28 May 2013 17:40:12 GMT

Amarin Corporation plc (ADR) (AMRN): What's The Smart Money Think?
Insider Monkey (blog) - May 28, 2013

Amarin Corporation plc (ADR) (NASDAQ:AMRN) was in 19 hedge funds' portfolio at the end of March. AMRN shareholders have witnessed a decrease in support from the world's most elite money managers recently.

Investors Buzz: Charles Schwab Corp (NYSE:SCHW), Real Goods Solar, Inc ... - Cogo

AMARIN CORPORATION PLC (ADR) : Amarin Announces Additional Effects of ...

Thu, 30 May 2013 10:45:17 GMT

AMARIN CORPORATION PLC (ADR) : Amarin Announces Additional Effects of ...
4-traders (press release) - May 30, 2013

BEDMINSTER, N.J. and DUBLIN, Ireland, May 30, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...

AMARIN CORPORATION PLC (ADR) : Amarin Announces Notification of Patent ...

Wed, 22 May 2013 10:58:17 GMT

AMARIN CORPORATION PLC (ADR) : Amarin Announces Notification of Patent ...
4-traders (press release) - May 22, 2013

BEDMINSTER, N.J., and DUBLIN, Ireland, May 22, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...

Technical Bull Stock Alert: Amarin Corporation Plc (ADR) (AMRN)

Wed, 29 May 2013 19:52:53 GMT

Technical Bull Stock Alert: Amarin Corporation Plc (ADR) (AMRN)
SBWire (press release) - May 29, 2013

Bridgewater, MA -- (SBWIRE) -- 05/29/2013 -- The online StockConsultant latest screen has found a biotech company that developes drugs for the treatment of cardiovascular diseases Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock with a 80% bullish ...

News Recap: Amarin Corporation plc, First Solar, Inc.(NASDAQ:FSLR), Alcatel ...

Thu, 30 May 2013 14:54:40 GMT

News Recap: Amarin Corporation plc, First Solar, Inc.(NASDAQ:FSLR), Alcatel ...
Cogo - May 30, 2013

Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock gained 6.50% to $6.88. The company, on May 30, presented additional data on Vascepa® (icosapent ethyl) and its effect on lipoprotein particle concentration from the Phase 3 ANCHOR study at the ...

Losers Buzz: Amarin Corporation plc, CYS Investments Inc, Wave Systems Corp ...

Wed, 29 May 2013 13:09:51 GMT

Losers Buzz: Amarin Corporation plc, CYS Investments Inc, Wave Systems Corp ...
Openglobe - May 29, 2013

Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock declined 5.75% to $6.39. The company, on May 22, announced that the United States Patent and Trademark Office (USPTO) has published notification of a Notice of Allowance for Amarin's U.S.

News Recap: McEwen Mining Inc, Amarin Corporation plc, AuRico Gold Inc ...

Fri, 31 May 2013 12:53:47 GMT

News Recap: McEwen Mining Inc, Amarin Corporation plc, AuRico Gold Inc ...
Openglobe - May 31, 2013

Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock gained 8.05% to $6.98. The company, on May 30, presented additional data on Vascepa® (icosapent ethyl) and its effect on lipoprotein particle concentration from the Phase 3 ANCHOR study at the ...

Hot Stocks, Vanda Pharmaceuticals, Biodel Inc, Gladstone Commercial ...

Wed, 19 Jun 2013 19:01:54 GMT

Hot Stocks, Vanda Pharmaceuticals, Biodel Inc, Gladstone Commercial ...
PR Carbon (press release) - 5 hours ago

Amarin Corporation plc (ADR) (NASDAQ:AMRN) receives FDA Advisory Committee date of of Oct 16th for Supplemental New Drug Application for Vascepa.

Right Drug Class, Wrong Company

Tue, 28 May 2013 22:31:17 GMT

Right Drug Class, Wrong Company
Motley Fool - May 28, 2013

We've been speculating for almost a year that Amarin (NASDAQ: AMRN ) would be purchased by AstraZeneca (NYSE: AZN ) . The large pharma sells cholesterol-lowering drug Crestor, which would be a perfect fit with Amarin's lipid-lowering fish oil Vascepa.

ADR Shares End Mostly Higher Amid Positive US Confidence, Housing Data - Wall Street Journal

This Drugmaker Should Go Fishing for a Marketing Partner

Sat, 01 Jun 2013 01:03:50 GMT

This Drugmaker Should Go Fishing for a Marketing Partner
Motley Fool - Jun 1, 2013

Today, in the third and final installment of three biotech companies that could desperately use a marketing partner, I would like to look more closely at Amarin (NASDAQ: AMRN ) , and discuss why I feel it would be wise to find a big pharma friend. Fish ...